Skip to main content

Peer Review reports

From: Oral pimonidazole unveils clinicopathologic and epigenetic features of hypoxic tumour aggressiveness in localized prostate cancer

Original Submission
9 Nov 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
29 Jan 2024 Reviewed Reviewer Report
7 May 2024 Reviewed Reviewer Report - Ioanna-Maria Grypari
27 May 2024 Author responded Author comments - Housheng Hansen He
Resubmission - Version 3
27 May 2024 Submitted Manuscript version 3
28 May 2024 Author responded Author comments - Housheng Hansen He
Resubmission - Version 4
28 May 2024 Submitted Manuscript version 4
1 Jun 2024 Reviewed Reviewer Report - Ioanna Maria Grypari
10 Jun 2024 Author responded Author comments - Housheng Hansen He
Resubmission - Version 5
10 Jun 2024 Submitted Manuscript version 5
Publishing
11 Jun 2024 Editorially accepted
18 Jun 2024 Article published 10.1186/s12885-024-12505-1

You can find further information about peer review here.

Back to article page